The Continuous Passive Motion Devices Market is estimated to be valued at USD 948.2 Mn in 2026 and is expected to reach approximately USD 1,352.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033. The market is undergoing steady development, mainly driven by the increasing number of knee and hip replacement procedures, rising prevalence of osteoarthritis and musculoskeletal disorders, expansion of postoperative rehabilitation services, and growing demand for home-based rehabilitation solutions. Continuous passive motion devices are motorized rehabilitation systems designed to move an affected joint repeatedly through a prescribed range of motion without requiring active muscular effort from the patient.

The market includes a wide range of joint-specific CPM systems, including knee, shoulder, hip, ankle, and other joint rehabilitation devices. These devices are available in portable and fixed configurations and are used across hospitals, ambulatory surgical centers, physiotherapy facilities, and home-based rehabilitation settings. Knee joint CPM devices are expected to represent the largest device category, accounting for approximately 41.0% of the market in 2026, owing to the high volume of knee replacement, ligament reconstruction, and other orthopedic procedures.

Healthcare providers are increasingly focusing on structured and patient-specific rehabilitation protocols to improve joint mobility, reduce postoperative stiffness, and facilitate functional recovery. The shift toward shorter hospital stays and outpatient orthopedic procedures is strengthening demand for portable CPM devices that can be transferred from hospitals or surgical centers to patients’ homes. Portable devices are expected to account for approximately 57.0% of the market in 2026, supported by ease of transportation, rental-based availability, simplified operation, and growing adoption of home-based postoperative rehabilitation.

Technological advancements involving programmable movement settings, digital range-of-motion tracking, adherence monitoring, mobility analytics, and remote clinician oversight are gradually transforming conventional CPM machines into connected rehabilitation platforms. However, future market adoption is expected to depend increasingly on clinical evidence, appropriate patient selection, reimbursement availability, and the ability of manufacturers to demonstrate measurable rehabilitation outcomes.

Market Dynamics

The Continuous Passive Motion Devices Market is witnessing sustained momentum owing to the increasing volume of orthopedic surgeries, particularly total knee replacement, hip replacement, ligament reconstruction, and joint-repair procedures. The U.K. National Joint Registry recorded 263,865 joint replacement procedures in 2024, including 134,652 knee procedures and 116,901 hip procedures, demonstrating the substantial patient base potentially requiring postoperative physiotherapy and mobility-restoration support.

The growing prevalence of osteoarthritis, joint degeneration, sports injuries, and age-related mobility impairment is also strengthening market demand. Approximately 595 Mn people globally were affected by osteoarthritis, representing around 15% of the population aged 30 years and above, and the affected population is projected to approach 1 Mn by 2050. The rapidly increasing elderly population is expected to further expand demand for orthopedic interventions and postoperative rehabilitation equipment.

The increasing transition from inpatient orthopedic care toward ambulatory surgical centers, shorter hospital stays, and home-based recovery is supporting the adoption of portable CPM devices. Hospitals remain the leading end-user segment and are projected to account for approximately 57.4% of the market in 2026, owing to the concentration of orthopedic surgeries, availability of surgeons and rehabilitation professionals, immediate postoperative monitoring, and institutional procurement of rehabilitation equipment.

The market is also benefiting from the gradual integration of digital monitoring, mobility analytics, and connected-care functions. Manufacturers are increasingly evaluating range-of-motion tracking, patient-adherence monitoring, programmable rehabilitation protocols, and remote clinician oversight to improve therapy personalization and demonstrate treatment outcomes. Moreover, multimodal rehabilitation approaches combining CPM therapy with active exercise, muscle-strengthening interventions, proprioceptive stimulation, and blood-flow-restriction training are expected to broaden the role of CPM devices within comprehensive recovery programs.

However, limited reimbursement coverage, high acquisition and maintenance costs, inconsistent clinical evidence for routine CPM use, and the availability of alternative physiotherapy methods may restrict market expansion. In the U.S., Medicare coverage for home-use knee CPM devices is generally limited to patients following total knee replacement, provided that treatment begins within two days of surgery and remains within the applicable portion of the subsequent three-week period. This restricted reimbursement window encourages short-term rental and hospital-to-home distribution models while limiting reimbursed adoption for shoulder, hip, ankle, and longer-duration applications.

The market’s future development is therefore expected to be concentrated in clinically selected patient groups, including individuals with limited active mobility, postoperative stiffness, complex joint reconstruction, delayed functional recovery, or specific rehabilitation requirements. Manufacturers that provide portable, programmable, connected, and outcome-oriented CPM systems are expected to be better positioned than companies offering conventional standalone devices.

Key Features of the Study

• This report provides in-depth analysis of the Continuous Passive Motion Devices Market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Continuous Passive Motion Devices Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include DJO global, Inc., Bio-Med Inc., BTL Corporate, Furniss Corporation, Chinesport S.p.a, RIMEC S.R.L. and OPED GmbH, Kinetec Medical Products UK Ltd., Comfortland Medical, and Mettler Electronic Corp.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Continuous Passive Motion Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Continuous Passive Motion Devices Market

Market Segmentation

• By Device Type (Revenue, USD Mn, 2021-2033)
  • Knee Joint CPM devices
  • Shoulder Joint CPM devices
  • Hip Joint CPM devices
  • Ankle Joint CPM devices
  • Other CPM devices
• By Age Group (Revenue, USD Mn, 2021-2033)
  • Children
  • Adult
• By Design (Revenue, USD Mn, 2021-2033)
  • Portable
  • Fixed
• By End User (Revenue, USD Mn, 2021-2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Home-based user
• By Region (Revenue, USD Mn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • DJO global, Inc.
  • Bio-Med Inc.
  • BTL Corporate
  • Furniss Corporation
  • Chinesport S.p.a
  • RIMEC S.R.L. and OPED GmbH
  • Kinetec Medical Products UK Ltd.
  • Comfortland Medical
  • Mettler Electronic Corp.